Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher M Booth

Showing results (121-130 of 349) with videos related to

Pageof 35
Sort By:
The Journal of Urology|March 30, 2021
No Outcome Differences after Cystectomy between Patients with De Novo Muscle-Invasive Bladder Cancer Compared to Progressors: A Retrospective Population-Based StudyAvril Lusty, R Christopher Doiron, Christopher M Booth, et al.
Bladder Cancer (Amsterdam, Netherlands)|November 13, 2018
Venous Thromboembolism and Peri-Operative Chemotherapy for Muscle-Invasive Bladder Cancer: A Population-based StudyKelly Brennan, Safiya Karim, R Christopher Doiron, et al.
Trends in Cancer|February 24, 2023
The unequal burden of time toxicityWhitney V Johnson, Anne H Blaes, Christopher M Booth, et al.
Cancer|June 21, 2023
Differential treatment effect between younger and older adults for new cancer therapies in solid tumors supporting US Food and Drug Administration approval between 2010 and 2021Brooke E Wilson, Alexandra Desnoyers, Michelle B Nadler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 28, 2019
Value of Biomarker Expression for Randomized Clinical Trial Design: One (More) Missed OpportunityFrancisco E Vera-Badillo, Andrew J Robinson, David M Berman, et al.
Cancer|September 26, 2023
Meta-analysis of sex and racial subgroup participation rates and differential treatment effects for trials in solid tumor malignancies leading to US Food and Drug Administration registration between 2010 and 2021Brooke E Wilson, Michelle B Nadler, Alexandra Desnoyers, et al.
The Journal of Urology|May 13, 2021
Reply by AuthorsAvril Lusty, R Christopher Doiron, Christopher M Booth, et al.
Journal of Palliative Care|January 19, 2022
Palliative Radiotherapy for Esophageal and Gastric Cancer: Population-Based Patterns of Utilization and Outcomes in Ontario, CanadaShaila J Merchant, Weidong Kong, Aamer Mahmud, et al.
Anesthesia and Analgesia|February 17, 2017
Association Between Anesthesiology Volumes and Early and Late Outcomes After Cystectomy for Bladder Cancer: A Population-Based StudyMelanie T Jaeger, D Robert Siemens, Xuejiao Wei, et al.
Current Oncology (Toronto, Ont.)|July 25, 2022
Choosing Wisely-Barriers and Solutions to Implementation in Low and Middle-Income CountriesFidel Rubagumya, Manju Sengar, Sidy Ka, et al.
Pageof 35

Showing results (121-130 of 349) with videos related to

Sort By:
Pageof 35
The Journal of Urology|March 30, 2021
No Outcome Differences after Cystectomy between Patients with De Novo Muscle-Invasive Bladder Cancer Compared to Progressors: A Retrospective Population-Based StudyAvril Lusty, R Christopher Doiron, Christopher M Booth, et al.
Bladder Cancer (Amsterdam, Netherlands)|November 13, 2018
Venous Thromboembolism and Peri-Operative Chemotherapy for Muscle-Invasive Bladder Cancer: A Population-based StudyKelly Brennan, Safiya Karim, R Christopher Doiron, et al.
Trends in Cancer|February 24, 2023
The unequal burden of time toxicityWhitney V Johnson, Anne H Blaes, Christopher M Booth, et al.
Cancer|June 21, 2023
Differential treatment effect between younger and older adults for new cancer therapies in solid tumors supporting US Food and Drug Administration approval between 2010 and 2021Brooke E Wilson, Alexandra Desnoyers, Michelle B Nadler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 28, 2019
Value of Biomarker Expression for Randomized Clinical Trial Design: One (More) Missed OpportunityFrancisco E Vera-Badillo, Andrew J Robinson, David M Berman, et al.
Cancer|September 26, 2023
Meta-analysis of sex and racial subgroup participation rates and differential treatment effects for trials in solid tumor malignancies leading to US Food and Drug Administration registration between 2010 and 2021Brooke E Wilson, Michelle B Nadler, Alexandra Desnoyers, et al.
The Journal of Urology|May 13, 2021
Reply by AuthorsAvril Lusty, R Christopher Doiron, Christopher M Booth, et al.
Journal of Palliative Care|January 19, 2022
Palliative Radiotherapy for Esophageal and Gastric Cancer: Population-Based Patterns of Utilization and Outcomes in Ontario, CanadaShaila J Merchant, Weidong Kong, Aamer Mahmud, et al.
Anesthesia and Analgesia|February 17, 2017
Association Between Anesthesiology Volumes and Early and Late Outcomes After Cystectomy for Bladder Cancer: A Population-Based StudyMelanie T Jaeger, D Robert Siemens, Xuejiao Wei, et al.
Current Oncology (Toronto, Ont.)|July 25, 2022
Choosing Wisely-Barriers and Solutions to Implementation in Low and Middle-Income CountriesFidel Rubagumya, Manju Sengar, Sidy Ka, et al.
Pageof 35